The IGF axis in the prostate

P. Cohen, D. M. Peehl, Ronald (Ron) Rosenfeld

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

The insulin-like growth factor (IGF) axis is a multi-component network of molecules involved in the regulation of cell growth. The axis includes two major ligands, (IGF-I and IGF-II), cell surface receptors, (the type I IGF receptor family as well as the type II IGF receptor), a family of high affinity binding proteins which regulate IGF availability to the receptors, (the IGFBPs), and a group of IGFBP proteases which cleave IGFBBPs and modulate IGF action. Human seminal plasma contains IGF-I and -II, IGFBP-2 and -4, as well as IGFBP-3 fragments and IGFBP3 protease activity. A prostatic source for these IGF-axis molecules is likely. We have demonstrated the human prostate to contain all the elements of a functional IGF system. Prostate fibroblasts in primary culture (PC-F) express mRNA for IGF-II and produce IGF-II peptide in biologically active concentrations. This IGF-II appears to be of a high molecular weight (15 kD) species. Prostate epithelial cells in primary culture (PC-E) express the type I IGF receptor. These cells also produce IGFBP-2 and -4, (on both mRNA and peptide levels), while PC-F secrete IGFBP-2, -3 and -4. PC-E are exquisitely sensitive to the mitogenic effects of IGFs. Finally, prostate specific antigen (PSA), secreted from PC- and found in seminal plasma, can function as a potent IGFBP-3 protease. This IGFBP-3 protease activity can remove the inhibitory effects of IGFBP-3 on IGF-I induced PC-3 growth. We have recently shown that PC-F from patients with benign prostatic hypertrophy (BPH) hyper-express mRNA for IGF-II. This observation and other related findings suggest a regression of these fibroblasts to a state reminiscent of fetal fibroblasts. This molecular alteration in a critical component of the prostatic IGF axis in BPH patients may also be involved in the pathogenesis of abnormal prostate epithelial proliferation.

Original languageEnglish (US)
Pages (from-to)81-84
Number of pages4
JournalHormone and Metabolic Research
Volume26
Issue number2
StatePublished - 1994
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor II
Somatomedins
Prostate
Insulin-Like Growth Factor Binding Protein 2
Insulin-Like Growth Factor Binding Protein 3
Fibroblasts
Insulin-Like Growth Factor I
Insulin-Like Growth Factor Binding Protein 4
Insulin-Like Growth Factor Binding Proteins
IGF Type 1 Receptor
Prostatic Hyperplasia
Semen
Messenger RNA
Peptide Hydrolases
IGF Type 2 Receptor
Plasma (human)
Network components
Peptides
Molecules
Cell Surface Receptors

Keywords

  • benign prostatic hyperplasia
  • binding proteins
  • cancer
  • epithelial cells
  • IGF receptors
  • IGFBP protease
  • insulin-like growth factors
  • prostate
  • seminal plasma
  • stromal cells

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Cohen, P., Peehl, D. M., & Rosenfeld, R. R. (1994). The IGF axis in the prostate. Hormone and Metabolic Research, 26(2), 81-84.

The IGF axis in the prostate. / Cohen, P.; Peehl, D. M.; Rosenfeld, Ronald (Ron).

In: Hormone and Metabolic Research, Vol. 26, No. 2, 1994, p. 81-84.

Research output: Contribution to journalArticle

Cohen, P, Peehl, DM & Rosenfeld, RR 1994, 'The IGF axis in the prostate', Hormone and Metabolic Research, vol. 26, no. 2, pp. 81-84.
Cohen P, Peehl DM, Rosenfeld RR. The IGF axis in the prostate. Hormone and Metabolic Research. 1994;26(2):81-84.
Cohen, P. ; Peehl, D. M. ; Rosenfeld, Ronald (Ron). / The IGF axis in the prostate. In: Hormone and Metabolic Research. 1994 ; Vol. 26, No. 2. pp. 81-84.
@article{7a16c583a8a6423984b1f1495b86fa4d,
title = "The IGF axis in the prostate",
abstract = "The insulin-like growth factor (IGF) axis is a multi-component network of molecules involved in the regulation of cell growth. The axis includes two major ligands, (IGF-I and IGF-II), cell surface receptors, (the type I IGF receptor family as well as the type II IGF receptor), a family of high affinity binding proteins which regulate IGF availability to the receptors, (the IGFBPs), and a group of IGFBP proteases which cleave IGFBBPs and modulate IGF action. Human seminal plasma contains IGF-I and -II, IGFBP-2 and -4, as well as IGFBP-3 fragments and IGFBP3 protease activity. A prostatic source for these IGF-axis molecules is likely. We have demonstrated the human prostate to contain all the elements of a functional IGF system. Prostate fibroblasts in primary culture (PC-F) express mRNA for IGF-II and produce IGF-II peptide in biologically active concentrations. This IGF-II appears to be of a high molecular weight (15 kD) species. Prostate epithelial cells in primary culture (PC-E) express the type I IGF receptor. These cells also produce IGFBP-2 and -4, (on both mRNA and peptide levels), while PC-F secrete IGFBP-2, -3 and -4. PC-E are exquisitely sensitive to the mitogenic effects of IGFs. Finally, prostate specific antigen (PSA), secreted from PC- and found in seminal plasma, can function as a potent IGFBP-3 protease. This IGFBP-3 protease activity can remove the inhibitory effects of IGFBP-3 on IGF-I induced PC-3 growth. We have recently shown that PC-F from patients with benign prostatic hypertrophy (BPH) hyper-express mRNA for IGF-II. This observation and other related findings suggest a regression of these fibroblasts to a state reminiscent of fetal fibroblasts. This molecular alteration in a critical component of the prostatic IGF axis in BPH patients may also be involved in the pathogenesis of abnormal prostate epithelial proliferation.",
keywords = "benign prostatic hyperplasia, binding proteins, cancer, epithelial cells, IGF receptors, IGFBP protease, insulin-like growth factors, prostate, seminal plasma, stromal cells",
author = "P. Cohen and Peehl, {D. M.} and Rosenfeld, {Ronald (Ron)}",
year = "1994",
language = "English (US)",
volume = "26",
pages = "81--84",
journal = "Hormone and Metabolic Research",
issn = "0018-5043",
publisher = "Georg Thieme Verlag",
number = "2",

}

TY - JOUR

T1 - The IGF axis in the prostate

AU - Cohen, P.

AU - Peehl, D. M.

AU - Rosenfeld, Ronald (Ron)

PY - 1994

Y1 - 1994

N2 - The insulin-like growth factor (IGF) axis is a multi-component network of molecules involved in the regulation of cell growth. The axis includes two major ligands, (IGF-I and IGF-II), cell surface receptors, (the type I IGF receptor family as well as the type II IGF receptor), a family of high affinity binding proteins which regulate IGF availability to the receptors, (the IGFBPs), and a group of IGFBP proteases which cleave IGFBBPs and modulate IGF action. Human seminal plasma contains IGF-I and -II, IGFBP-2 and -4, as well as IGFBP-3 fragments and IGFBP3 protease activity. A prostatic source for these IGF-axis molecules is likely. We have demonstrated the human prostate to contain all the elements of a functional IGF system. Prostate fibroblasts in primary culture (PC-F) express mRNA for IGF-II and produce IGF-II peptide in biologically active concentrations. This IGF-II appears to be of a high molecular weight (15 kD) species. Prostate epithelial cells in primary culture (PC-E) express the type I IGF receptor. These cells also produce IGFBP-2 and -4, (on both mRNA and peptide levels), while PC-F secrete IGFBP-2, -3 and -4. PC-E are exquisitely sensitive to the mitogenic effects of IGFs. Finally, prostate specific antigen (PSA), secreted from PC- and found in seminal plasma, can function as a potent IGFBP-3 protease. This IGFBP-3 protease activity can remove the inhibitory effects of IGFBP-3 on IGF-I induced PC-3 growth. We have recently shown that PC-F from patients with benign prostatic hypertrophy (BPH) hyper-express mRNA for IGF-II. This observation and other related findings suggest a regression of these fibroblasts to a state reminiscent of fetal fibroblasts. This molecular alteration in a critical component of the prostatic IGF axis in BPH patients may also be involved in the pathogenesis of abnormal prostate epithelial proliferation.

AB - The insulin-like growth factor (IGF) axis is a multi-component network of molecules involved in the regulation of cell growth. The axis includes two major ligands, (IGF-I and IGF-II), cell surface receptors, (the type I IGF receptor family as well as the type II IGF receptor), a family of high affinity binding proteins which regulate IGF availability to the receptors, (the IGFBPs), and a group of IGFBP proteases which cleave IGFBBPs and modulate IGF action. Human seminal plasma contains IGF-I and -II, IGFBP-2 and -4, as well as IGFBP-3 fragments and IGFBP3 protease activity. A prostatic source for these IGF-axis molecules is likely. We have demonstrated the human prostate to contain all the elements of a functional IGF system. Prostate fibroblasts in primary culture (PC-F) express mRNA for IGF-II and produce IGF-II peptide in biologically active concentrations. This IGF-II appears to be of a high molecular weight (15 kD) species. Prostate epithelial cells in primary culture (PC-E) express the type I IGF receptor. These cells also produce IGFBP-2 and -4, (on both mRNA and peptide levels), while PC-F secrete IGFBP-2, -3 and -4. PC-E are exquisitely sensitive to the mitogenic effects of IGFs. Finally, prostate specific antigen (PSA), secreted from PC- and found in seminal plasma, can function as a potent IGFBP-3 protease. This IGFBP-3 protease activity can remove the inhibitory effects of IGFBP-3 on IGF-I induced PC-3 growth. We have recently shown that PC-F from patients with benign prostatic hypertrophy (BPH) hyper-express mRNA for IGF-II. This observation and other related findings suggest a regression of these fibroblasts to a state reminiscent of fetal fibroblasts. This molecular alteration in a critical component of the prostatic IGF axis in BPH patients may also be involved in the pathogenesis of abnormal prostate epithelial proliferation.

KW - benign prostatic hyperplasia

KW - binding proteins

KW - cancer

KW - epithelial cells

KW - IGF receptors

KW - IGFBP protease

KW - insulin-like growth factors

KW - prostate

KW - seminal plasma

KW - stromal cells

UR - http://www.scopus.com/inward/record.url?scp=0028354126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028354126&partnerID=8YFLogxK

M3 - Article

C2 - 8200618

AN - SCOPUS:0028354126

VL - 26

SP - 81

EP - 84

JO - Hormone and Metabolic Research

JF - Hormone and Metabolic Research

SN - 0018-5043

IS - 2

ER -